Skip to main content

Table 3 Current available antiretroviral drugs in Thailand

From: Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand

Generic Name Abbreviation Dosage form Adult dose
Nucleoside reverse transcriptase inhibitors (NRTIs)  
Lamivudine 3TC 150, 300 mg, 10 mg/ml 150 mg q 12 h or 300 mg OD
Abacavir ABV 300 mg 300 mg q 12 h or 600 mg OD
Zidovudine AZT 100, 300 mg, 10 mg/ml 200 - 300 mg q 12 h
Stavudine d4T 15, 20, 30 mg 30 mg q 12 h
5 mg/ml
Didanosine DDI 250, 400 mg (extended release capsule) ≤60 kg 250 mg OD, > 60 kg 400 mg OD
25, 125, 200 mg (Buffer tablet) with TDF ≤60 kg 200 mg OD, > 60 kg 250 mg OD on empty stomach
Tenofovir TDF 300 mg 1 tab OD
Combined NRTIs    
Zidovudine + Lamivudine AZT/3TC 300/150 mg 1 tab q 12 h
Abacavir + Lamivudine ABV/3TC 600/300 mg 1 tab OD
Tenofovir + Emtricitabine TDF/FTC 300/200 mg 1 tab OD
Stavudine + Lamivudine D4T/3TC 30/150 mg 1 tab q 12 h
Non-Nucleoside reverse transcriptase inhibitors (NNRTIs)  
Rilpivirine RPV 25 mg 1 tab OD with meal
Efavirenz EFV 50, 200, 600 mg 600 mg OD hs, on empty stomach to reduce side effect
Etravirine ETR 100 mg 2 tab q 12 h with meal
Nevirapine NVP 200 mg, 10 mg/ml 200 mg q 12 h or 400 mg OD
Combine NRTIs + NNRTIs    
Tenofovir + Emtricitabine + Efavirenz TDF/FTC/EFV 300/200/600 mg 1 tab OD hs, on empty stomach to reduce side effect
Stavudine + Lamivudine + Nevirapine GPO vir S 30/150/200 mg 1 tab q 12 h
Zidovudine + Lamivudine + Nevirapine GPO vir Z 250 250/150/200 mg 1 tab q 12 h
Protease inhibitors (PIs)    
Atazanavir ATV 200, 300 mg 300 mg OD (boosted rtv), 400 mg OD, with TDF 300 mg OD (boosted rtv) with EFV
400 mg (boosted rtv), with meal
Darunavir DRV 300, 600 mg 600 mg q 12 h, 800 mg OD with meal
Indinavir IDV 200, 400 mg 800 mg q 12 h
Lopinavir/ritonavir LPV/rtv 100/25, 200/50 mg, 80/20 mg/ml 400/100 mg q 12 h or 800/200 mg OD
Ritonavir RTV 100 mg boosted RTV 100 mg q12 h or OD
Saquinavir SQV 500 mg 2 tab q 12 h
CCR5 Inhibitor (CCR5I)    
Maraviroc MRV 150, 300 mg 150 mg q 12 h with strong cyp 3A inh. (with or without 3A ind.) ex. PIs except TPV/r
    300 mg q 12 h with NRTIs, T20, NVP, RAL,TPV/r and other drug that not strong 3A inh./ind.
    600 mg q 12 h with cyp 3A ind ex. EFV, ETR (without 3A inh.)
Integrase inhibitors    
Raltegravir 400 mg RAL 400 mg 1 tab q 12 h